Refine by
Blood Brain Suppliers In Canada
5 companies found
based inCambridge, MASSACHUSETTS (USA)
At BlueRock, our mission is to create authentic cellular medicines to reverse devastating diseases, with the vision of improving the human condition. Until recently, scientists believed that mature adult cells were permanently locked into their ...
With our cell+gene platform, BlueRock is aiming to redefine the very way we treat disease, moving from addressing mere symptoms to restoring health lost to cell damage or degeneration. Instead of prescribing a pill to treat tremors in patients with ...
based inKirkland, Montréal, QUEBEC (CANADA)
Jubilant Radiopharma is a global leader in the development, manufacturing, and commercialization of radiopharmaceuticals used for the diagnosis and treatment of disease. We serve our customers – and through them patients – with high-quality and ...
Each kit consists of reaction vials which contain the sterile, non-pyrogenic, non-radioactive ingredients necessary to produce Technetium Tc 99m Pentetate Injection for diagnostic use by intravenous injection or for inhalation after the nebulization ...
based inMississauga, ONTARIO (CANADA)
Award-winning, Clinical Stage/Life-Sciences company focused on the drug discovery and development of next-generation targeted therapeutics within the endocannabinoid system and specific brain receptors. The company is targeting anxiety, depression, ...
Mentanine®, supported by (cannabidiol “CBD” + IP formula) – molecules bond and synergistically attach to PPAR receptors allowing the formula to cross the blood-brain barrier ...
based inGloucestershire, UNITED KINGDOM
Renishaw is a global, high precision metrology and healthcare technology group. We design, develop and deliver solutions and systems that provide unparalleled precision, control and reliability. We are also a world leader in the field of additive ...
Novel chronic and acute catheter systems for direct delivery of therapeutics to the ...
based inGaithersburg, MARYLAND (USA)
As a global life sciences company, Emergent offers specialized products to healthcare providers and governments to address medical needs and emerging health threats. Protecting and Enhancing 50 million lives by 2025 focuses our energy to improve the ...
Raxibacumab is indicated for the treatment of adult and pediatric patients with inhalational anthrax due to Bacillus anthracis in combination with appropriate antibacterial drugs. Raxibacumab is also indicated for prophylaxis of inhalational anthrax ...